Sortation Korea/Overseas Patent Grants Registration number
AKC
KR Process for preparing lymphocytes comprising activated natural killer cells for targeting cancer cells and pharmaceutical composition comprising the same 10-1298012
AKC
KR Method and composition for proliferating of natural killer cell 10-1909879
AKC
JP Method and composition for proliferating of natural killer cell 6073417
Cord STEM
US Process for isolating vascular endothelial cells from embryoid bodies differentiated from embryonic stem cells
7919318
FMD-NPC
KR Process for differentiation of human neural progenitor cells to dopaminergic neurons and medium for differentiation thereof 10-1106020
FMD-NPC
KR Method for proliferating neuronal progenitor cells and composition for treating nervous diseases comprising the neuronal progenitor cells 10-1662792
FMD-NPC
CN Process for differentiation of human neural progenitor cells to dopaminergic neurons and medium for differentiation thereof 2985535
FMD-NPC
US Process for differentiation of human neural progenitor cells to dopaminergic neurons and medium for differentiation thereof 8921107
FMD-NPC
EP Process for differentiation of human neural progenitor cells to dopaminergic neurons and medium for differentiation thereof 2581443
FMD-NPC
JP Process for differentiation of human neural progenitor cells to dopaminergic neurons and medium for differentiation thereof 5776101
FMD-NPC
JP Method for proliferating neuronal progenitor cells and composition for treating nervous diseases comprising the neuronal progenitor cells 1662793
FMD-NPC
AU Process for differentiation of human neural progenitor cells to dopaminergic neurons and medium for differentiation thereof 265956
FMD-NPC
CA Process for differentiation of human neural progenitor cells to dopaminergic neurons and medium for differentiation thereof 2802661
hESC-RPE
KR Improved Modalities for the Treatment of Degenerative Disease of the Retina 10-1258292
hESC-RPE
KR Improved Modalities for the Treatment of Degenerative Disease of the Retina 10-1398356
hESC-RPE
KR Derivation of Embryonic Stem Cells and Embryo-Derived Cells 10-1569204
hESC-RPE
KR
Derivation of Embryonic Stem Cells and Embryo-Derived Cells
10-1602951
hESC-RPE
KR
Improved Methods of Producing RPE Cells and Compositions of RPE Cells
10-1849329
hESC-RPE
KR
Improved Methods of Producing RPE Cells and Compositions of RPE Cells
10-1849336
hESC-RPE
US Embryonic Stem Cell-Derived Cardiomyocytes and a Cellular Therapeutic Agent Comprising the Same as an Active Ingredient 9969978
PLX-PAD
KR Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy 10-1490449
PLX-PAD
KR Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy 10-1557256
PLX-PAD
KR Devices and methods for culture of cells 10-1678796
PLX-PAD
KR Composition for treating ischemia comprising adherent cells from placenta tissues 10-1738285
PLX-PAD
KR Adherent cells from adipose or placenta tissues and use thereof in therapy 10-1738323
PLX-PAD
KR Methods and systems for harvesting cells 10-1910685
 
 
 
CEO Message
Vision
History
Overseas Corporations
Affiliated Companies
Business Overview
Cord Blood Banking Business
Bio Insurance Business
CHAUM Business(Non-medical)
IT Business
Other Businesses
CHA Biotech R&D Center
R&D Pipeline
Current Status of Clinical Trials
Patent Grants (Korea/Overseas)
Scientific Publications
Corporate Filings
Stock Information
IR Presentations